Atrys Health SL Cash Flow Conversion Efficiency
Atrys Health SL cash flow conversion efficiency. Based on the latest financial reports, Atrys Health SL (ATRY) has a cash flow conversion efficiency ratio of -0.031x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-4.67 Million ≈ $-5.46 Million USD) by net assets (€151.96 Million ≈ $177.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Atrys Health SL (2015–2025)
Cash flow conversion efficiency of Atrys Health SL from 2015 to 2025. This chart illustrates how Atrys Health SL's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Atrys Health SL share price for real-time trading data and today's change.
Atrys Health SL Cash Flow Conversion Ratio Explained
Atrys Health SL cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Atrys Health SL Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Atrys Health SL ranked by their cash flow conversion efficiency. Also see ATRY company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lightron Inc.
KQ:069540
|
-0.041x |
|
Kalekim Kimyevi Maddeler Sanayi & Ticaret AS
IS:KLKIM
|
-0.010x |
|
Grupo Hotelero Santa Fe SAB
MX:HOTEL
|
0.019x |
|
Mastersystem Infotama Tbk.
JK:MSTI
|
-0.053x |
|
Garanti Faktoring AS
IS:GARFA
|
-0.186x |
|
Caregen Co.Ltd
KQ:214370
|
0.019x |
|
Politeknik Metal Sanayi ve
IS:POLTK
|
0.228x |
|
Sekerbank TAS
IS:SKBNK
|
0.497x |
Annual Cash Flow Conversion Efficiency for Atrys Health SL (2015–2025)
The table below shows the annual cash flow conversion efficiency of Atrys Health SL from 2015 to 2025. Review cash generation quality of Atrys Health SL to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €151.96 Million ≈ $177.65 Million |
€-1.56 Million ≈ $-1.82 Million |
-0.010x | -186.69% |
| 2024-12-31 | €253.24 Million ≈ $296.07 Million |
€3.00 Million ≈ $3.50 Million |
0.012x | +413.87% |
| 2023-12-31 | €289.88 Million ≈ $338.90 Million |
€-1.09 Million ≈ $-1.28 Million |
-0.004x | +91.75% |
| 2022-12-31 | €337.57 Million ≈ $394.66 Million |
€-15.43 Million ≈ $-18.04 Million |
-0.046x | -366.86% |
| 2021-12-31 | €273.98 Million ≈ $320.31 Million |
€4.69 Million ≈ $5.49 Million |
0.017x | +192.45% |
| 2020-12-31 | €75.33 Million ≈ $88.07 Million |
€-1.40 Million ≈ $-1.63 Million |
-0.019x | -168.34% |
| 2019-12-31 | €39.95 Million ≈ $46.71 Million |
€1.08 Million ≈ $1.27 Million |
0.027x | +178.48% |
| 2018-12-31 | €26.44 Million ≈ $30.91 Million |
€-913.68K ≈ $-1.07 Million |
-0.035x | -161.14% |
| 2017-12-31 | €23.30 Million ≈ $27.24 Million |
€1.32 Million ≈ $1.54 Million |
0.057x | +201.57% |
| 2016-12-31 | €14.26 Million ≈ $16.68 Million |
€-793.63K ≈ $-927.84K |
-0.056x | -258.82% |
| 2015-12-31 | €11.70 Million ≈ $13.68 Million |
€409.89K ≈ $479.21K |
0.035x | -- |
About Atrys Health SL
Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through three segments: Diagnosis, Oncology, and Preventive Medicine. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; telediagnosis activities in the fi… Read more